PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat rare cancers
Disease control TerminatedThis study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New attack on deadly cancer: powerful drug combo before surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy before surgery helps fight pleural mesothelioma more effectively. It involves 41 adults with early-stage, operable mesothelioma who haven't had prior cancer treatment. Patients rec…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC